EUVIMEDEUVIMED entdecken
Open Access

Strategies to Increase Equitable Access to Penicillin Allergy Delabeling Interactions

Alysse Wurcel, Danielle Crabtree, Olabimpe Asupoto, Madelyn Eippert, Yvane Ngassa, Rachel Tam, Ivana Kohut, Kap Sum Foong, Valerie Stone, Denise Daudelin, Stephen Bartels, Kimberly G Blumenthal

JAMA Network Open · 15.09.2026 · 9 (9) · e2633825

DOI: 10.1001/jamanetworkopen.2026.33825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 15.09.2026. Verfasst von Alysse Wurcel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts. Hauptthemen laut MEDLINE: Penicillins, Drug Hypersensitivity, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patients with unconfirmed and potentially false penicillin allergy labels receive unnecessarily broad-spectrum antibiotics that can lead to worse health outcomes and antimicrobial resistance. While ambulatory care is a favorable setting to engage in penicillin allergy delabeling, the process of removing an incorrect penicillin allergy label has not been widely implemented.

Objective

To contextualize barriers to and facilitators of penicillin allergy delabeling from a diverse range of perspectives and inform actionable strategies. Design, Setting, and Participants This qualitative study used in-depth interviews and focus groups with patients who had a penicillin allergy label, clinicians, and other stakeholders from primary care clinics in 3 hospital networks in Boston, Massachusetts. Participants were recruited from March 1 through September 30, 2024. Main Outcome and Measures The primary outcome was participant-perceived factors influencing engagement in discussions about penicillin allergy delabeling. The analytic approach was informed by the updated Consolidated Framework for Implementation Research (CFIR), with a mixed inductive-deductive analysis that incorporated the CFIR Expert Recommendations for Implementing Change (ERIC) implementation strategy matching tool to map interview data to implementation strategies.

Results

The study included 119 participants (84 [71%] female), of whom 69 (58%) were patients and 50 (42%) were clinicians and stakeholders; 87 (73%) participated in interviews and 32 (27%) participated in focus groups. Six barriers to penicillin allergy delabeling emerged: (1) clinician avoidance of conversations about penicillin allergy labels, (2) patients not being asked about their penicillin allergy labels, (3) language barriers, (4) time constraints, (5) perceived elevated risk of removing a penicillin allergy, and (6) limited access to allergists. These barriers aligned with 5 ERIC strategies: (1) create new ways of delivering care, (2) identify champions, (3) use data experts, (4) alter incentive structures, and (5) conduct educational meetings. Conclusions and Relevance This qualitative study guided by implementation science identified strategies to overcome barriers to penicillin allergy delabeling. These strategies may inform the next steps for implementation science research to improve access to penicillin allergy testing and delabeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PenicillinsDrug HypersensitivityAnti-Bacterial AgentsHumansFemaleQualitative ResearchMaleMiddle AgedFocus GroupsAdultAgedBoston

Substanzen

PenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts.
  • Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts.
  • Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts.
  • Division of Allergy and Clinical Immunology, Massachusetts General Hospital, Boston.
  • Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts.
  • Division of Pulmonary Allergy and Sleep, Mayo Clinic, Jacksonville, Florida.

Zitieren

APA

Wurcel, A., Crabtree, D., Asupoto, O., Eippert, M., Ngassa, Y., Tam, R., Kohut, I., Foong, K. S., Stone, V., Daudelin, D., Bartels, S., & Blumenthal, K. G. (2026). Strategies to Increase Equitable Access to Penicillin Allergy Delabeling Interactions. JAMA Network Open, 9(9), e2633825. https://doi.org/10.1001/jamanetworkopen.2026.33825

Vancouver

Wurcel A, Crabtree D, Asupoto O, Eippert M, Ngassa Y, Tam R, et al. Strategies to Increase Equitable Access to Penicillin Allergy Delabeling Interactions. JAMA Network Open. 2026;9(9):e2633825. doi:10.1001/jamanetworkopen.2026.33825

BibTeX
@article{Wurcel2026,
  author = {Wurcel, Alysse and Crabtree, Danielle and Asupoto, Olabimpe and Eippert, Madelyn and Ngassa, Yvane and Tam, Rachel and Kohut, Ivana and Foong, Kap Sum and Stone, Valerie and Daudelin, Denise and Bartels, Stephen and Blumenthal, Kimberly G},
  title = {Strategies to Increase Equitable Access to Penicillin Allergy Delabeling Interactions},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {9},
  pages = {e2633825},
  doi = {10.1001/jamanetworkopen.2026.33825}
}
Kostenlos starten →